|
| Age (years) | Total n = 4201 | p-value | ||||
|
| 20 - 29 n = 353 | 30 - 39 n = 1301 | 40 - 49 n = 1601 | 50 - 59 n = 758 | ≥60 n = 188 | ||
Thermage | Xa | 331 | 890 | 1011 | 460 | 109 | 2801 | p < 0.001 |
| 93.8% | 68.4% | 63.1% | 60.7% | 58.0% | 66.7% |
| |
O | 22 | 411 | 590 | 298 | 79 | 1400 |
| |
| 6.2% | 31.6% | 36.9% | 39.3% | 42.0% | 33.3% |
| |
Eye thermage | X | 352 | 1267 | 1540 | 721 | 182 | 4062 | 0.001 |
| 99.7% | 97.4% | 96.2% | 95.1% | 96.8% | 96.7% |
| |
O | 1 | 34 | 61 | 37 | 6 | 139 |
| |
| .3% | 2.6% | 3.8% | 4.9% | 3.2% | 3.3% |
| |
PDO thread lift | X | 339 | 1241 | 1511 | 684 | 166 | 3941 | p < 0.001 |
| 96.0% | 95.4% | 94.4% | 90.2% | 88.3% | 93.8% |
| |
O | 14 | 60 | 90 | 74 | 22 | 260 |
| |
| 4.0% | 4.6% | 5.6% | 9.8% | 11.7% | 6.2% |
| |
Silhouette soft thread | X | 352 | 1283 | 1571 | 717 | 180 | 4103 | p < 0.001 |
| 99.7% | 98.6% | 98.1% | 94.6% | 95.7% | 97.7% |
| |
O | 1 | 18 | 30 | 41 | 8 | 98 |
| |
| .3% | 1.4% | 1.9% | 5.4% | 4.3% | 2.3% |
| |
Nasolabial fold filler | X | 327 | 1162 | 1442 | 682 | 168 | 3781 | 0.479 |
| 92.6% | 89.3% | 90.1% | 90.0% | 89.4% | 90.0% |
| |
O | 26 | 139 | 159 | 76 | 20 | 420 |
| |
| 7.4% | 10.7% | 9.9% | 10.0% | 10.6% | 10.0% |
| |
Masseter botulinum toxin | X | 93 | 766 | 1206 | 644 | 175 | 2884 | p < 0.001 |
| 26.3% | 58.9% | 75.3% | 85.0% | 93.1% | 68.7% |
| |
O | 260 | 535 | 395 | 114 | 13 | 1317 |
| |
| 73.7% | 41.1% | 24.7% | 15.0% | 6.9% | 31.3% |
| |
Glabella lines botulinum toxin | X | 311 | 1073 | 1127 | 472 | 101 | 3084 | P < 0.001 |
| 88.1% | 82.5% | 70.4% | 62.3% | 53.7% | 73.4% |
| |
O | 42 | 228 | 474 | 286 | 87 | 1117 |
| |
| 11.9% | 17.5% | 29.6% | 37.7% | 46.3% | 26.6% |
| |
Horizontal forehead lines botulinum toxin | X | 331 | 1105 | 1175 | 554 | 127 | 3292 | p < 0.001 |
| 93.8% | 84.9% | 73.4% | 73.1% | 67.6% | 78.4% |
| |
O | 22 | 196 | 426 | 204 | 61 | 909 |
| |
| 6.2% | 15.1% | 26.6% | 26.9% | 32.4% | 21.6% |
| |
Lateral canthal lines botulinum toxin | X | 340 | 1157 | 1230 | 568 | 120 | 3415 | p < 0.001 |
| 96.3% | 88.9% | 76.8% | 74.9% | 63.8% | 81.3% |
| |
O | 13 | 144 | 371 | 190 | 68 | 786 |
| |
| 3.7% | 11.1% | 23.2% | 25.1% | 36.2% | 18.7% |
|